The study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of the University of California, San Diego. Study subjects were 15 healthy, nonsmoking volunteers, recruited from university employees (age range, 53–71 years). Written informed consent was obtained. Exclusion criteria included myopia over 3 D, use of routine medication that might affect IOP, and the presence of ocular disease. All subjects underwent a complete ophthalmic examination consisting of a medical history, best corrected visual acuity, slit lamp biomicroscopy, Goldmann applanation tonometry, and dilated funduscopy during office hours. Subjects also had a normal visual field test (using Statpac II, full-threshold 24-2; Zeiss Humphrey Field Analyzer, Carl Zeiss Meditec, Inc., Dublin, CA). We sought to recruit a representative sample of older adults. Therefore, subjects taking routine medications for chronic age-related conditions, such as systemic anticholesterol, antihypertensive, antiinflammatory, antidepressant, and estrogen replacement drugs were not restricted.
Individuals were selected who had a regular daily sleep cycle of approximately 8 hours. Before the laboratory session, they were instructed to maintain an accustomed 8-hour sleep period with lights off and lying down for 7 days. They were required to wear a wrist-mounted device (Actiwatch; Mini Mitter, Sunriver, OR) to monitor physical activity and light exposure and to keep a wake–sleep log. They were instructed to abstain from alcohol for 3 days and coffee intake for 1 day before the laboratory session.
Subjects reported to the sleep laboratory at approximately 2 PM and stayed indoors for 24 hours. Laboratory conditions were strictly controlled as in the previous study that enrolled healthy younger subjects whose data were available for comparisons.
1 The 8-hour period of darkness in each subjects' room was adjusted to correspond to the individual's sleep cycle, and the clock times for the IOP measurements were individualized correspondingly. For data presentation, clock times were normalized as if each subject slept from 11 PM to 7 AM.
1
Measurements of IOP in both eyes were taken by experienced examiners every 2 hours in the supine and then in the sitting position with a pneumatonometer (Model 30 Classic; Reichert, Depew, NY). The device has a resolution of 0.5 mm Hg. Measurements were always taken first in the right eye. Proparacaine 0.5% was applied to the eye for local anesthesia. A hard-copy printout was produced for each measurement and inspected visually. Before the nocturnal/sleep period, IOP was measured at 3:30, 5:30, 7:30, and 9:30 PM. The subjects were instructed to lie on the bed for 5 minutes before the supine IOP measurements, and they then assumed a vertical position for 5 minutes before the sitting IOP measurements. Blood pressure and heart rate were measured immediately before the IOP measurements. Lights were turned off at 11:00 PM and nocturnal measurements were taken at 11.30 PM and 1:30, 3:30, and 5:30 AM. The subjects were awakened, if necessary, and the supine measurements were taken immediately under dim light (<10 lux). The subjects resumed the sitting position, and IOP was measured 5 minutes later. Their light exposure was kept to a minimum during the nocturnal period. When the assigned nocturnal period ended at 7 AM, room lights were turned on and subjects were awakened, if necessary. IOP measurements were taken again at 7:30, 9:30, and 11:30 AM and 1:30 PM, as described previously. Food and water were available at all times, and meal times were not regulated. Room activities were continuously videotaped for 24 hours by infrared cameras.
The IOPs from both eyes were averaged and used for data analysis. The mean sitting and supine IOPs were calculated at each time point. Postural IOP changes were determined as the difference between the IOP measured in the sitting and supine positions. The postural IOP changes were averaged for the diurnal period (eight data points) and the nocturnal period (four data points). Using the best-fitting cosine curve,
14 we estimated the 24-hour IOP rhythms for each subject in both body positions. With the 12 IOP time points, a cosine-fit curve was generated for each subject in sitting and supine. The cosinor method was used to characterize the 24-hour rhythm of variables and measure acrophase and amplitude. The acrophase (cosinor analysis-derived peak time) represented the phase timing. The amplitudes (half distance between the cosine-fit maximum and minimum) provided the simulated variation for the 24-hour rhythm. The null hypothesis that phase timings were distributed randomly in 24 hours was tested with the Rayleigh test.
15 A significant difference would indicate a synchronized 24-hour rhythm for the group. The acrophases and amplitudes of supine IOP and sitting IOP were compared using the Wilcoxon signed rank test for paired data within the group of older subjects.
P < 0.05 indicated statistically significant. Results from this group of older subjects were compared with results from a group of healthy younger subjects whose data were collected under the same conditions.
1